Evidence map›Paper›PMID 41926436›Full record

ArticlePLOS global public health2026

Interrogating a framework for diabetic retinopathy screening adherence: Qualitative insights from a severely affected and under-adherent population.

Julia Fu, Joana Andoh, Elizabeth Fairless, June Weiss, Althea Norcott, Kristen Nwanyanwu

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia FuDepartment of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States of America.ORCID https://orcid.org/0000-0003-4351-9534
Joana AndohDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0001-6750-4113
Elizabeth FairlessDepartment of Ophthalmology and Visual Science, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States of America.ORCID https://orcid.org/0000-0002-1028-7610
June WeissDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Althea NorcottCommunity Contributor, New Haven, Connecticut, United States of America.
Kristen NwanyanwuDepartment of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States of America.ORCID https://orcid.org/0000-0003-1146-7733

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To validate and expand upon a framework of diabetic retinopathy (DR) screening adherence by examining barriers and facilitators among individuals with severe DR and those under-adherent to screening. From March 2021 to February 2022, we conducted eight remote semi-structured interviews with adults with diabetes across two participant populations: (1) participants with severe DR who had undergone procedures (n = 4) and (2) participants under-adherent to screening, defined as no eye exam in >1 year (n = 4). We recruited participants from the Yale Eye Center and community referrals. During the interviews, we collected demographic data and presented participants with a DR screening adherence framework previously developed by our group. We transcribed all interviews and conducted analyses using a hybrid deductive-inductive analytic approach informed by grounded theory techniques to identify recurring themes. Themes across both participant populations aligned with the existing framework, including vision status, emotional context, competing concerns, resource availability, cues to action, knowledge-creating experiences, and in-clinic experiences. The patient-doctor relationship emerged as a sub-theme of in-clinic experiences, highlighting the role of trust and communication in supporting sustained eye care engagement. At the individual level, participants with stable vision often perceived no need for screening. At the institutional and structural level, participants identified lack of insurance and transportation as significant barriers. These findings support the robustness of the DR screening adherence framework across varying levels of disease severity and engagement. Interventions that improve patient education, address structural barriers, and strengthen patient-doctor relationships may enhance screening adherence among populations at high risk for vision loss.

Identifiers

PMID41926436
PMCPMC13046135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.